| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.093 | 0.06 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.06 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.094 | 0.06 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.06 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.085 | 0.06 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.07 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.07 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.094 | 0.07 |